Spotlight
Video

ALK/EGFR inhibitor AP26113 commentary - Dr. Ron Burkes

Loading........
Description: For more updates visit www.oncologyeducation.com....

Dr. Ron Burkes with commentary on Abstract #3401: Updated results of a first-in-human dose-finding study of the ALK/EGFR inhibitor AP26113 in patients with advanced malignancies.
Shared By : oncologyeducation
Posted on : 10/07/13
Added : 3 years ago
Category : General



More From oncologyeducation

Nothing found.